Hepatitis

On Thursday, June 11, HepVu convened a webinar to discuss the impact of COVID-19 on harm reduction services, issues encountered on the ground, and potential solutions.

In collaboration with the National Viral Hepatitis Roundtable (NVHR), the Hepatitis Education Project (HEP), NASTAD, Hep B United, Hepatitis B Foundation, and National Association of County Health Officials (NACCHO), HepVu created a factsheet outlining the impact of the COVID-19 pandemic on viral hepatitis and the experiences of clinical providers, community-based organizations, and health departments during COVID-19.

The plan highlights goal-oriented objectives and strategies aimed at ultimately eliminating viral hepatitis as a public health threat in the U.S.

This document presents CDC's Division of Viral Hepatitis (DVH) 2025 goals and strategies to reduce new viral hepatitis infections, reduce viral hepatitis-related morbidity and mortality, and reduce viral hepatitis-related disparities.

This annual surveillance report, summarizes information about reported cases of hepatitis A, hepatitis B, and hepatitis C and deaths with either of these hepatitis listed as a cause of death in CDC’s National Vital Statistics System (NVSS).

This factsheet provides an overview of Hepatitis C.

This session discusses why representation, including of persons living with hepatitis B, is essential to research, and communication and outreach strategies to improve diversity in clinical trials.

This 30 second PSA shows a doctor encouraging people born in Vietnam, or whose parents were born in Vietnam, to get tested for hepatitis B.

This 30 second PSA highlights the importance of taking care of your liver by getting tested for hepatitis B.

Hepatitis A, hepatitis B, and hepatitis C are three types of viral hepatitis. Learn how each hepatitis virus affects the liver differently, has different routes of transmission, and has different populations that are commonly affected.